Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nhale (NHLE) CEO Endorses Texas Medical Cannabis Bills

CDXQ

HOUSTON, TX / ACCESSWIRE / March 18, 2015 / Nhale Inc.'s (OTCQB:NHLE) CEO Lance Williams today commented on the bills introduced by Texas lawmakers last Friday calling for comprehensive medical marijuana legislation that would allow patients suffering from serious conditions to access the plant with a doctor's prescription. "Among the negative consequences of marijuana prohibition, none is as unfortunate as the deprivation of medical marijuana to the tens of thousands of patients who could benefit from its therapeutic use," said Williams.

Rep. Marisa Marquez (D-El Paso) introduced House Bill 3785 and Sen. Jose Menendez (D-San Antonio) introduced a companion bill in the Senate to provide safe and legal access to medical marijuana.

"Historically, Texas has led the nation in innovative medical research. We trust the state will take the scientific and reasonable approach to the known benefits of medical marijuana and join the 23 other states that allow people with qualifying medical conditions to access medical cannabis," said Williams. "Marijuana has been shown to be a valuable aid in the treatment of a broad range of clinical applications, including pain relief, nausea, spasticity, glaucoma and movement disorders. We encourage Texas lawmakers to review the studies and support this legislation."

More than 60 U.S. and international health organizations support granting patients access to medical marijuana, including the American Academy of Family Physicians, the American Nurses Association, the Multiple Sclerosis Society, New England Journal of Medicine and the National Association for Public Health Policy, as reported by NORML.

Three out of four Texans, or 77 percent, feel seriously ill people should be able to access marijuana for treatment, according to a University of Texas/Texas Tribune poll released in February, 2014.

Nhale is actively pursuing acquisition opportunities in the cannabis market and is in talks with a corporation in Oregon regarding a collaborative effort to acquire multiple legal marijuana wholesale grow operations and dispensaries.

About Nhale, Inc. (OTCQB: NHLE)

Nhale(TM) is a U.S. company actively pursuing acquisition opportunities in the rapidly expanding marijuana industry. Nhale acquires companies with valid business models positioned to make a significant impact within the medical and recreational cannabis market. NHLE brings operating talent, tools and leadership to emerging companies in the space, promoting industry awareness and developing economically sustainable partnerships while increasing shareholder value.

For further information visit http://nhaleinc.com/investors.html.

Forward-Looking Statements

Certain information provided in this press release constitutes forward-looking statements. The words "anticipate", "expect", "project", "estimate", "forecast" and similar expressions are intended to identify such forward-looking statements. The reader is cautioned that assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be incorrect. Actual results achieved during the forecast period will vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. You can find a discussion of those risks and uncertainties in our EDGAR securities filings with the Securities and Exchange Commission. Such factors include, but are not limited to: general economic, market and business conditions; fluctuations in the marijuana market; the results of product development and the result of our efforts to develop strategic relationships, partnerships and potential acquisitions that are in line with our business model; outcome of partnership negotiations; the uncertainty of market estimates; changes in environmental and other regulations; risks associated with retail operations; and other factors, many of which are beyond the control of the Company. There is no representation by Nhale that actual results achieved during the forecast period will be the same in whole or in part as those forecast. Except as may be required by applicable securities laws, Nhale assumes no obligation to publicly update or revise any forward-looking statements made herein or otherwise, whether as a result of new information, future events or otherwise.

Contact

Nhale, Inc.
Lance Williams, President and CEO
281-671-6877

SOURCE: Nhale, Inc.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today